Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Genesis partner helps fund gene research; stock up

Genesis Research’s new partner to provide novel technology path to market; stock soars

By Peter Kerr

Oct. 23 (BusinessWire) – Genesis Research and Development’s search for a partner to bankroll further novel technology applications has resulted in a new subsidiary company financed by a Japanese investment fund.

MATF-1, part of Tokyo stock exchange listed MediBIC, is to invest up to $1 million in new Genesis subsidiary Solirna Biosciences Ltd., for the joint venture to develop single strand RNAi technology. The technology requires further research to enable delivery of specific gene silencing strands to targets such cancer tumours.

Genesis shares jumped 18% on the news to 7.cents on the NZX today. The Auckland-based biotechnology company has targeted immune disorders and cancer since its 1994 establishment, with the share price trading as high as $7.55 in February 2001. Its somewhat fraught history mirrors that of other biotechnology companies attempting to commercialise research into saleable products. Part of Genesis’ knowledge base is around gene silencing, now to be developed to market readiness through Solirna.

MediBIC’s mission is ‘personalised medicine,' concentrating on `pharmacogenomics,’ with a number of Asian and North American investments and collaborations. MATF-1 is one of its funding vehicles.

“MATF-1 wanted an equity position in the SSRNAi technology rather than funding Genesis,” said Genesis chief executive Stephen Hall.

Genesis’ special meeting today is necessary because the proposed investment by MATF-1 is more than half Genesis’ sharemarket capitalisation. The agreed value of the gene silencing technology is $2.2 million, compared to a recent Genesis average market capitalisation of $3 million.

If shareholders agree to the formation of the new subsidiary company they can expect a proof-of-concept product by the end of 2010, said Hall in his presentation.

Scaling up of production and manufacturing of product should begin in 2011. A number of points of the commercialisation process have been indicated as points to either exit or obtain further investment.

Hall said the funds from the deal are required by Genesis to maintain its structure and capability while realising some of its other assets and developing Solirna. At the same time, the deal with MATF-1 allows Genesis to use the gene silencing technology in agriculture and horticulture biotech.


© Scoop Media

Business Headlines | Sci-Tech Headlines


Frog Recruitment: Kiwi Workers Reluctant To Make Business Trips Across The Ditch Despite Trans-Tasman Bubble Opening

When the trans-Tasman travel bubble opens today, many Kiwi companies won't be rushing to buy an air ticket, reluctant to cross the ditch to do business. The latest survey conducted by leading recruitment agency, Frog Recruitment of nearly 1,000 New Zealand ... More>>

Tourism: Employers Welcome Back Working Holidaymakers

Tourism businesses gearing up for the return of Australian visitors from next week will be relieved to learn that they will also have access to an offshore pool of much-needed job candidates, Tourism Industry Aotearoa says. Tourism employers around ... More>>

Commerce Commission: Latest Broadband Report Confirms Improved Performance Of Premium Fibre Plans

The latest report from the Commerce Commission’s Measuring Broadband New Zealand programme shows that the performance of Fibre Max plans has improved substantially. This follows a collaboration between the Commission, its independent testing partner, ... More>>

Air New Zealand: Capital Raise Deferred

Air New Zealand has decided to defer its planned capital raise to later in 2021 allowing more time to assess the impacts of recent developments on the airline’s path to recovery. 'We’ve seen some clearing of COVID-19 clouds recently, with ... More>>

Stats NZ: New Report Shows Impact Of Demands On Land In New Zealand

A new environmental report released today by the Ministry for the Environment and Stats NZ, presents new data on New Zealand’s land cover, soil quality, and land fragmentation. The land cover data in the report, Our land 2021 , provides the most ... More>>


Stats NZ: March Card Spending Rebounds Despite COVID

There was a lift in retail card spending in March following a fall in the lockdown-disrupted February month, Stats NZ said today. Seasonally adjusted retail card spending rose by $53 million (0.9 percent), compared with February 2021. Visit our website to read ... More>>

PwC: Outcome Of Review Into Air New Zealand Gas Turbines Business

Air New Zealand has received the report into its Gas Turbines business from independent external advisers PwC. Air New Zealand Chairman Dame Therese Walsh says the report identified a range of effective controls in the Gas Turbines revenue contracting ... More>>